Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,177
archived clinical trials in
Orthopedic

An Extension Study of Ataluren (PTC124) in Participants With Nonsense Mutation Dystrophinopathy
A Phase 3 Extension Study of Ataluren (PTC124) in Patients With Nonsense Mutation Dystrophinopathy
Status: Enrolling
Updated:  12/31/1969
Seattle Children's Hospital - Childhood Cancer and Blood Disorders
3
mi
from 98109
Seattle, WA
An Extension Study of Ataluren (PTC124) in Participants With Nonsense Mutation Dystrophinopathy
A Phase 3 Extension Study of Ataluren (PTC124) in Patients With Nonsense Mutation Dystrophinopathy
Status: Enrolling
Updated: 12/31/1969
Seattle Children's Hospital - Childhood Cancer and Blood Disorders
3
mi
from 98109
Seattle, WA
Click here to add this to my saved trials
An Extension Study of Ataluren (PTC124) in Participants With Nonsense Mutation Dystrophinopathy
A Phase 3 Extension Study of Ataluren (PTC124) in Patients With Nonsense Mutation Dystrophinopathy
Status: Enrolling
Updated:  12/31/1969
Children's Hospital at Westmead
7755
mi
from 98109
Westmead,
An Extension Study of Ataluren (PTC124) in Participants With Nonsense Mutation Dystrophinopathy
A Phase 3 Extension Study of Ataluren (PTC124) in Patients With Nonsense Mutation Dystrophinopathy
Status: Enrolling
Updated: 12/31/1969
Children's Hospital at Westmead
7755
mi
from 98109
Westmead,
Click here to add this to my saved trials
An Extension Study of Ataluren (PTC124) in Participants With Nonsense Mutation Dystrophinopathy
A Phase 3 Extension Study of Ataluren (PTC124) in Patients With Nonsense Mutation Dystrophinopathy
Status: Enrolling
Updated:  12/31/1969
Stanford Univ Med Ctr
704
mi
from 98109
Stanford, CA
An Extension Study of Ataluren (PTC124) in Participants With Nonsense Mutation Dystrophinopathy
A Phase 3 Extension Study of Ataluren (PTC124) in Patients With Nonsense Mutation Dystrophinopathy
Status: Enrolling
Updated: 12/31/1969
Stanford Univ Med Ctr
704
mi
from 98109
Stanford, CA
Click here to add this to my saved trials
An Extension Study of Ataluren (PTC124) in Participants With Nonsense Mutation Dystrophinopathy
A Phase 3 Extension Study of Ataluren (PTC124) in Patients With Nonsense Mutation Dystrophinopathy
Status: Enrolling
Updated:  12/31/1969
Children's Hospital of Cincinnati
1967
mi
from 98109
Cincinnati, OH
An Extension Study of Ataluren (PTC124) in Participants With Nonsense Mutation Dystrophinopathy
A Phase 3 Extension Study of Ataluren (PTC124) in Patients With Nonsense Mutation Dystrophinopathy
Status: Enrolling
Updated: 12/31/1969
Children's Hospital of Cincinnati
1967
mi
from 98109
Cincinnati, OH
Click here to add this to my saved trials
A Skills-Based Program Delivered Via Secure Live Video to Patients With Acute Musculoskeletal Trauma
A Randomized Controlled Trial Testing a Skills-Based Program Called "A Toolkit for Optimal Recovery" Delivered Via Secure Live Video Compared to Standard Medical Care in Patients With Acute Musculoskeletal Injuries
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital
2485
mi
from 98109
Boston, MA
A Skills-Based Program Delivered Via Secure Live Video to Patients With Acute Musculoskeletal Trauma
A Randomized Controlled Trial Testing a Skills-Based Program Called "A Toolkit for Optimal Recovery" Delivered Via Secure Live Video Compared to Standard Medical Care in Patients With Acute Musculoskeletal Injuries
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
Database Retrieval for the Comprehensive Shoulder
Comprehensive Shoulder System Database Retrieval
Status: Enrolling
Updated:  12/31/1969
Acromion LLC
2325
mi
from 98109
Towson, MD
Database Retrieval for the Comprehensive Shoulder
Comprehensive Shoulder System Database Retrieval
Status: Enrolling
Updated: 12/31/1969
Acromion LLC
2325
mi
from 98109
Towson, MD
Click here to add this to my saved trials
A Novel System to Detect Falls in Real-life Conditions
Status: Enrolling
Updated:  12/31/1969
Brigham and Women's Hosp
2485
mi
from 98109
Boston, MA
A Novel System to Detect Falls in Real-life Conditions
Status: Enrolling
Updated: 12/31/1969
Brigham and Women's Hosp
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
Pre-hospital Advanced Therapies for Control of Hemorrhage - Pelvis
Pre-hospital Advanced Therapies for Control of Hemorrhage (PATCH) - Pelvis
Status: Enrolling
Updated:  12/31/1969
Carolinas Medical Center
2281
mi
from 98109
Charlotte, NC
Pre-hospital Advanced Therapies for Control of Hemorrhage - Pelvis
Pre-hospital Advanced Therapies for Control of Hemorrhage (PATCH) - Pelvis
Status: Enrolling
Updated: 12/31/1969
Carolinas Medical Center
2281
mi
from 98109
Charlotte, NC
Click here to add this to my saved trials
Glenohumeral Rotation After Throwing: RCT Comparing the Sleeper Stretch to the 90/90 Hip Lift With Balloon Blow Exercise
Restoration of Glenohumeral Internal Rotation Deficit (GIRD) After Throwing: A Randomized Clinical Trail Comparing the Sleeper Stretch to the 90/90 Hip Lift With Balloon Blow Exercise
Status: Enrolling
Updated:  12/31/1969
Duke University
2341
mi
from 98109
Durham, NC
Glenohumeral Rotation After Throwing: RCT Comparing the Sleeper Stretch to the 90/90 Hip Lift With Balloon Blow Exercise
Restoration of Glenohumeral Internal Rotation Deficit (GIRD) After Throwing: A Randomized Clinical Trail Comparing the Sleeper Stretch to the 90/90 Hip Lift With Balloon Blow Exercise
Status: Enrolling
Updated: 12/31/1969
Duke University
2341
mi
from 98109
Durham, NC
Click here to add this to my saved trials
RCT Determining Best Treatment for Geriatric Acetabular Fractures
Randomized Controlled Trial to Determine the Best Treatment of Acetabular Fractures in Geriatric Patients: Open Reduction Internal Fixation With or Without Primary Total Hip Arthroplasty
Status: Enrolling
Updated:  12/31/1969
University of Maryland Department of Orthopaedics
2328
mi
from 98109
Baltimore, MD
RCT Determining Best Treatment for Geriatric Acetabular Fractures
Randomized Controlled Trial to Determine the Best Treatment of Acetabular Fractures in Geriatric Patients: Open Reduction Internal Fixation With or Without Primary Total Hip Arthroplasty
Status: Enrolling
Updated: 12/31/1969
University of Maryland Department of Orthopaedics
2328
mi
from 98109
Baltimore, MD
Click here to add this to my saved trials
Impact of Different Educational Approaches on Post-operative Opiate Utilization After Elective Lower Extremity Surgery
The Effect of an Educational Pain Approach Before Elective Lower-extremity Surgery on 6-month Post-operative Use of Opioid Medication: A Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
Brooke Army Medical Center
1787
mi
from 98109
San Antonio, TX
Impact of Different Educational Approaches on Post-operative Opiate Utilization After Elective Lower Extremity Surgery
The Effect of an Educational Pain Approach Before Elective Lower-extremity Surgery on 6-month Post-operative Use of Opioid Medication: A Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Brooke Army Medical Center
1787
mi
from 98109
San Antonio, TX
Click here to add this to my saved trials
Early Anti-inflammatory Treatment in Patients With Acute ACL Tear and Painful Effusions
Early Anti-inflammatory Treatment in Patients With Acute ACL Tear and Painful Effusions
Status: Enrolling
Updated:  12/31/1969
UK Healthcare at Turfland
2004
mi
from 98109
Lexington, KY
Early Anti-inflammatory Treatment in Patients With Acute ACL Tear and Painful Effusions
Early Anti-inflammatory Treatment in Patients With Acute ACL Tear and Painful Effusions
Status: Enrolling
Updated: 12/31/1969
UK Healthcare at Turfland
2004
mi
from 98109
Lexington, KY
Click here to add this to my saved trials
Aquatic vs. Land Locomotor Training Overground Locomotor Training in Improving Ambulatory Function and Health-Related Quality of Life
The Efficacy of Aquatic Locomotor Training Compared to Overground Locomotor Training in Improving Ambulatory Function and Health-Related Quality of Life
Status: Enrolling
Updated:  12/31/1969
Cristina Sadowsky, M.D.
2329
mi
from 98109
Baltimore, MD
Aquatic vs. Land Locomotor Training Overground Locomotor Training in Improving Ambulatory Function and Health-Related Quality of Life
The Efficacy of Aquatic Locomotor Training Compared to Overground Locomotor Training in Improving Ambulatory Function and Health-Related Quality of Life
Status: Enrolling
Updated: 12/31/1969
Cristina Sadowsky, M.D.
2329
mi
from 98109
Baltimore, MD
Click here to add this to my saved trials
Efficacy and Safety Study of SUNPG1622
A Randomized, Double-blind, Placebo-controlled Phase 2a Study to Evaluate the Efficacy and Safety of Tildrakizumab in Subjects With Active Ankylosing Spondylitis or Non-radiographic Axial Spondyloarthritis
Status: Enrolling
Updated:  12/31/1969
SPARC Site 1
2019
mi
from 98109
Middleburg Heights, OH
Efficacy and Safety Study of SUNPG1622
A Randomized, Double-blind, Placebo-controlled Phase 2a Study to Evaluate the Efficacy and Safety of Tildrakizumab in Subjects With Active Ankylosing Spondylitis or Non-radiographic Axial Spondyloarthritis
Status: Enrolling
Updated: 12/31/1969
SPARC Site 1
2019
mi
from 98109
Middleburg Heights, OH
Click here to add this to my saved trials
The Effect of EXPAREL® on Postsurgical Pain, and the Use of Narcotics
The Effect of EXPAREL® on Postsurgical Pain, and the Use of Narcotics
Status: Enrolling
Updated:  12/31/1969
Andrews Research and Education Foundation, Inc.
2206
mi
from 98109
Gulf Breeze, FL
The Effect of EXPAREL® on Postsurgical Pain, and the Use of Narcotics
The Effect of EXPAREL® on Postsurgical Pain, and the Use of Narcotics
Status: Enrolling
Updated: 12/31/1969
Andrews Research and Education Foundation, Inc.
2206
mi
from 98109
Gulf Breeze, FL
Click here to add this to my saved trials
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated:  12/31/1969
Medical Affiliated Research Center, Inc.
2038
mi
from 98109
Huntsville, AL
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated: 12/31/1969
Medical Affiliated Research Center, Inc.
2038
mi
from 98109
Huntsville, AL
Click here to add this to my saved trials
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated:  12/31/1969
Urology Group of Westrn Arkansas
1663
mi
from 98109
Fort Smith, AR
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated: 12/31/1969
Urology Group of Westrn Arkansas
1663
mi
from 98109
Fort Smith, AR
Click here to add this to my saved trials
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated:  12/31/1969
South Orange County Medical Research Center
999
mi
from 98109
Laguna Hills, CA
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated: 12/31/1969
South Orange County Medical Research Center
999
mi
from 98109
Laguna Hills, CA
Click here to add this to my saved trials
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated:  12/31/1969
California Professionnal Research
992
mi
from 98109
Newport Beach, CA
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated: 12/31/1969
California Professionnal Research
992
mi
from 98109
Newport Beach, CA
Click here to add this to my saved trials
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated:  12/31/1969
William G. Moseley
1063
mi
from 98109
San Diego, CA
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated: 12/31/1969
William G. Moseley
1063
mi
from 98109
San Diego, CA
Click here to add this to my saved trials
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated:  12/31/1969
West Coast Clinical Research
950
mi
from 98109
Tarzana, CA
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated: 12/31/1969
West Coast Clinical Research
950
mi
from 98109
Tarzana, CA
Click here to add this to my saved trials
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated:  12/31/1969
Western Clinical Research
975
mi
from 98109
Torrance, CA
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated: 12/31/1969
Western Clinical Research
975
mi
from 98109
Torrance, CA
Click here to add this to my saved trials
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated:  12/31/1969
Urology Research Options
1027
mi
from 98109
Aurora, CO
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated: 12/31/1969
Urology Research Options
1027
mi
from 98109
Aurora, CO
Click here to add this to my saved trials
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated:  12/31/1969
Urologic Oncology
1027
mi
from 98109
Aurora, CO
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated: 12/31/1969
Urologic Oncology
1027
mi
from 98109
Aurora, CO
Click here to add this to my saved trials
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated:  12/31/1969
Genitourinary Surgical Consultants
1024
mi
from 98109
Denver, CO
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated: 12/31/1969
Genitourinary Surgical Consultants
1024
mi
from 98109
Denver, CO
Click here to add this to my saved trials
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated:  12/31/1969
Connecticut Clincal Research Center
2417
mi
from 98109
Middlebury, CT
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated: 12/31/1969
Connecticut Clincal Research Center
2417
mi
from 98109
Middlebury, CT
Click here to add this to my saved trials
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated:  12/31/1969
South Florida Medical Research
2725
mi
from 98109
Aventura, FL
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated: 12/31/1969
South Florida Medical Research
2725
mi
from 98109
Aventura, FL
Click here to add this to my saved trials
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated:  12/31/1969
Tampa Bay Medical Research Inc.
2511
mi
from 98109
Clearwater, FL
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated: 12/31/1969
Tampa Bay Medical Research Inc.
2511
mi
from 98109
Clearwater, FL
Click here to add this to my saved trials
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated:  12/31/1969
Atlantic Urological Associates
2530
mi
from 98109
Daytona Beach, FL
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated: 12/31/1969
Atlantic Urological Associates
2530
mi
from 98109
Daytona Beach, FL
Click here to add this to my saved trials
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated:  12/31/1969
Miami VACM
2729
mi
from 98109
Miami, FL
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated: 12/31/1969
Miami VACM
2729
mi
from 98109
Miami, FL
Click here to add this to my saved trials
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated:  12/31/1969
Florida Healthcare Research
2483
mi
from 98109
Ocala, FL
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated: 12/31/1969
Florida Healthcare Research
2483
mi
from 98109
Ocala, FL
Click here to add this to my saved trials
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated:  12/31/1969
Florida Urologist Specialists
2553
mi
from 98109
Sarasota, FL
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated: 12/31/1969
Florida Urologist Specialists
2553
mi
from 98109
Sarasota, FL
Click here to add this to my saved trials
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated:  12/31/1969
Southeastern Research Group
2329
mi
from 98109
Tallahassee, FL
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated: 12/31/1969
Southeastern Research Group
2329
mi
from 98109
Tallahassee, FL
Click here to add this to my saved trials
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated:  12/31/1969
Southwestern Medical Research Institute
2206
mi
from 98109
Columbus, GA
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated: 12/31/1969
Southwestern Medical Research Institute
2206
mi
from 98109
Columbus, GA
Click here to add this to my saved trials
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated:  12/31/1969
Northwestern University Feinberg School of Medecine
1733
mi
from 98109
Chicago, IL
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated: 12/31/1969
Northwestern University Feinberg School of Medecine
1733
mi
from 98109
Chicago, IL
Click here to add this to my saved trials
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated:  12/31/1969
Welborn Clinic
1865
mi
from 98109
Evansville, IN
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated: 12/31/1969
Welborn Clinic
1865
mi
from 98109
Evansville, IN
Click here to add this to my saved trials
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated:  12/31/1969
Northeast Indiana Research
1871
mi
from 98109
Fort Wayne, IN
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated: 12/31/1969
Northeast Indiana Research
1871
mi
from 98109
Fort Wayne, IN
Click here to add this to my saved trials
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated:  12/31/1969
Kansas City Urology Care, PA
1507
mi
from 98109
Overland Park, KA
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated: 12/31/1969
Kansas City Urology Care, PA
1507
mi
from 98109
Overland Park, KA
Click here to add this to my saved trials
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated:  12/31/1969
Four Rivers Clinical Research
1854
mi
from 98109
Paducah, KY
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated: 12/31/1969
Four Rivers Clinical Research
1854
mi
from 98109
Paducah, KY
Click here to add this to my saved trials
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated:  12/31/1969
Myron I Murdock MD LLC
2325
mi
from 98109
Greenbelt, MD
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated: 12/31/1969
Myron I Murdock MD LLC
2325
mi
from 98109
Greenbelt, MD
Click here to add this to my saved trials
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated:  12/31/1969
Michigan Institute of Urology
1934
mi
from 98109
Saint Clair Shores, MI
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated: 12/31/1969
Michigan Institute of Urology
1934
mi
from 98109
Saint Clair Shores, MI
Click here to add this to my saved trials
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated:  12/31/1969
Washington University
1716
mi
from 98109
Saint Louis, MO
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated: 12/31/1969
Washington University
1716
mi
from 98109
Saint Louis, MO
Click here to add this to my saved trials
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated:  12/31/1969
Metropolitan Urological Specialists
1709
mi
from 98109
Saint Louis, MO
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated: 12/31/1969
Metropolitan Urological Specialists
1709
mi
from 98109
Saint Louis, MO
Click here to add this to my saved trials
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated:  12/31/1969
Quality Clinical Research, Inc.
1361
mi
from 98109
Omaha, NE
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated: 12/31/1969
Quality Clinical Research, Inc.
1361
mi
from 98109
Omaha, NE
Click here to add this to my saved trials
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated:  12/31/1969
Delaware Valley Urology, LLC
2384
mi
from 98109
Westampton, NJ
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated: 12/31/1969
Delaware Valley Urology, LLC
2384
mi
from 98109
Westampton, NJ
Click here to add this to my saved trials
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated:  12/31/1969
Urology Group of New Mexico
1183
mi
from 98109
Albuquerque, NM
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated: 12/31/1969
Urology Group of New Mexico
1183
mi
from 98109
Albuquerque, NM
Click here to add this to my saved trials
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated:  12/31/1969
Medical & Clinical Research Associates
2436
mi
from 98109
Bay Shore, NY
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated: 12/31/1969
Medical & Clinical Research Associates
2436
mi
from 98109
Bay Shore, NY
Click here to add this to my saved trials
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated:  12/31/1969
Urological Surgeons of Long Island, Clinical Research Division
2418
mi
from 98109
Garden City, NY
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated: 12/31/1969
Urological Surgeons of Long Island, Clinical Research Division
2418
mi
from 98109
Garden City, NY
Click here to add this to my saved trials
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated:  12/31/1969
New York University School of Medecine
2402
mi
from 98109
New York, NY
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated: 12/31/1969
New York University School of Medecine
2402
mi
from 98109
New York, NY
Click here to add this to my saved trials
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated:  12/31/1969
University Urology
2402
mi
from 98109
New York, NY
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated: 12/31/1969
University Urology
2402
mi
from 98109
New York, NY
Click here to add this to my saved trials